Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial
Matthew J. Matasar, Nancy L. Bartlett, Mazyar Shadman, Lihua E. Budde, Ian W. Flinn, Gareth P. Gregory, Won Seog Kim, Georg Heß, Dima El‐Sharkawi, Catherine Diefenbach, Huang Huang, Iris To, Joana Parreira, Mei Wu, Antonia Kwan, Sarit Assouline
Topics & Concepts
MedicineInternal medicineCytokine release syndromeFollicular lymphomaNeutropeniaLymphomaAdverse effectFebrile neutropeniaGastroenterologyTumor lysis syndromeRefractory (planetary science)RituximabCyclophosphamideOncologySurgeryCancerChemotherapyImmunotherapyPhysicsAstrobiologyChimeric antigen receptorCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies ResearchHER2/EGFR in Cancer Research